HEB - Hemispherx Biopharma, Inc.

NYSE American - NYSE American Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 58.68M
Enterprise Value 310.79M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)49.03
Price/Book (mrq)1.34
Enterprise Value/Revenue 360.98
Enterprise Value/EBITDA 6-1.01

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Sep 30, 2018

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-6,565.54%

Management Effectiveness

Return on Assets (ttm)-48.59%
Return on Equity (ttm)-123.77%

Income Statement

Revenue (ttm)177k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)-57.80%
Gross Profit (ttm)-746k
EBITDA -10.7M
Net Income Avi to Common (ttm)-10.2M
Diluted EPS (ttm)-0.2550
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)4.08M
Total Cash Per Share (mrq)0.09
Total Debt (mrq)5.95M
Total Debt/Equity (mrq)92.45
Current Ratio (mrq)1.00
Book Value Per Share (mrq)0.13

Cash Flow Statement

Operating Cash Flow (ttm)-8.98M
Levered Free Cash Flow (ttm)-5.66M

Trading Information

Stock Price History

Beta (3Y Monthly) 0.46
52-Week Change 3-40.18%
S&P500 52-Week Change 3-0.99%
52 Week High 30.6500
52 Week Low 30.1500
50-Day Moving Average 30.2076
200-Day Moving Average 30.2616

Share Statistics

Avg Vol (3 month) 3264.31k
Avg Vol (10 day) 3210.58k
Shares Outstanding 548.19M
Float 46.9M
% Held by Insiders 12.64%
% Held by Institutions 15.02%
Shares Short (Nov 15, 2018) 4448.04k
Short Ratio (Nov 15, 2018) 41.41
Short % of Float (Nov 15, 2018) 40.97%
Short % of Shares Outstanding (Nov 15, 2018) 40.93%
Shares Short (prior month Oct 15, 2018) 4445.72k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 212/1
Last Split Date 3Aug 29, 2016